Data as of Q4 2025 (Dec 31, 2025)

Cormorant Asset Management, LP

โ€ขCIK: 1583977โ€ขFiling: Q4 2025

**Cormorant Asset Management, LP** manages $2.2B across a concentrated portfolio of 35 positions. The firm exhibits significant conviction in key sectors, highlighted by its top holdings including PRAX at $280.0M and BBOT at $223.8M. Further allocations are notable in technology and indices, with ABVX at $182.1M and NDQ at $153.6M. This structure suggests a tactical, high-conviction approach to market opportunities.

Total AUM
$1.8B
+ $398.6M in options
QoQ Performance
+21.7%
Positions
32
+ 3 options
Top 10 Concentration
69.4%
Latest Filing
Q4 2025

Top Holdings Allocation

PRAX
BBOT
ABVX
NDQ
EYPT
IWM
XBI
PRAX12.9%
BBOT10.4%
ABVX8.4%
NDQ7.1%
EYPT7.0%
IWM5.7%
XBI5.6%
RAPP4.2%

๐Ÿ“ˆ Biggest Buys

NDQPUT
INVESCO QQQ TR
NEW
7.1% of portfolio
IWMPUT
ISHARES TR
NEW
5.7% of portfolio
XBIPUT
SPDR SERIES TRUST
NEW
5.6% of portfolio
OLMA
OLEMA PHARMACEUTICALS INC
NEW
3.2% of portfolio
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
+118.4%
2.7% of portfolio

๐Ÿ“‰ Biggest Sells

ABVX
ABIVAX SA
-30.8%
8.4% of portfolio
NAMS
NEWAMSTERDAM PHARMA COMPANY
-54.0%
1.6% of portfolio
IM8N
INSMED INC
-36.0%
2.2% of portfolio
EWTX
EDGEWISE THERAPEUTICS INC
-18.1%
3.8% of portfolio
BBIO
BRIDGEBIO PHARMA INC
-14.3%
4.2% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

ACLX
ARCELLX INC
SOLD
$63.6M
CGON
CG ONCOLOGY INC
SOLD
$25.2M
KRRO
KORRO BIO INC
SOLD
$22.3M
โ€”
METSERA INC
SOLD
$20.9M
RNAGBP
AVIDITY BIOSCIENCES INC
SOLD
$13.1M
+2 more exited positions

Changes from Q3 2025

NEW6 new positions
โ†‘3 increased
โ†“22 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023